You are here: Industry Insights > Biotherapeutics

News List

Live Biotherapeutics: Targeting The Microbiome For The Cancer Treatment Shruti Talashi
March 18, 2024
The quest to create microbial products that can influence cancer outcomes has been rekindled by the mounting evidence of the role that microbiota plays in human health and illness.
Fujifilm Acquires Cell Therapy Mfg. Facility from Atara Biotherapeutics contractpharma
January 27, 2022
Expands its advanced therapies CDMO business .
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct prnasia
January 11, 2022
Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering...
FDA Accepts Arcutis Biotherapeutics’ New Drug Application for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis Drugs
December 27, 2021
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S. Food and Drug Administration’s (FDA)...
Northwest Biotherapeutics Receives MHRA Approval of License for GMP Manufacturing in UK contractpharma
December 22, 2021
Enables the manufacturing of DCVax-L products to get under way at the Sawston facility.
SAB Biotherapeutics’ SAB-185 shows activity against Omicron variant in study Pharmaceutical-Technology
December 20, 2021
SAB Biotherapeutics has reported that its antibody SAB-185 for Covid-19 retained neutralisation activity against the Omicron variant of SARS-CoV-2 in an in vitro pseudovirus model.
IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting prnasia
December 13, 2021
IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing innovative medicines and Innovent Biologics, Inc. ("Innovent", HKEX: 01801)...
Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics clinical programs prnasia
December 09, 2021
Servatus Ltd, an unlisted Australian biopharmaceutical company and global expert in the identification and development of novel autoimmune therapies using live microbial biotherapeutics and engineered proteins...
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics ExpressPharma
November 19, 2021
Twist Bioscience Corporation has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and commercialize an antibody...
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China prnasia
October 20, 2021
Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company focused on developing novel drugs for inflammation, fibrosis and oncology, announced that the first subject has been dosed in the China Phase I clinical trial of BBT-401...